Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy OptiNose stock | $2.75

Learn how to easily invest in OptiNose stock.

OptiNose Inc is a drug manufacturers-specialty & generic business based in the US. OptiNose shares (OPTN) are listed on the NASDAQ and all prices are listed in US Dollars. OptiNose employs 204 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in OptiNose

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OPTN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

OptiNose stock price (NASDAQ: OPTN)

Use our graph to track the performance of OPTN stocks over time.

OptiNose shares at a glance

Information last updated 2021-10-24.
Latest market close$2.75
52-week range$2.32 - $5.11
50-day moving average $2.91
200-day moving average $3.07
Wall St. target price$14.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.83

Buy OptiNose shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OptiNose stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OptiNose price performance over time

Historical closes compared with the close of $2.75 from 2021-10-26

1 week (2021-10-21) -5.50%
1 month (2021-09-28) -5.82%
3 months (2021-07-28) 1.48%
6 months (2021-04-28) -25.47%
1 year (2020-10-28) -22.32%
2 years (2019-10-28) -63.04%
3 years (2018-10-26) 11.19
5 years (2016-10-24) N/A

OptiNose financials

Revenue TTM $62.1 million
Gross profit TTM $41.6 million
Return on assets TTM -34.21%
Return on equity TTM -1050.5%
Profit margin -152.39%
Book value $0.13
Market capitalisation $150.9 million

TTM: trailing 12 months

Shorting OptiNose shares

There are currently 3.0 million OptiNose shares held short by investors – that's known as OptiNose's "short interest". This figure is 3.2% down from 3.1 million last month.

There are a few different ways that this level of interest in shorting OptiNose shares can be evaluated.

OptiNose's "short interest ratio" (SIR)

OptiNose's "short interest ratio" (SIR) is the quantity of OptiNose shares currently shorted divided by the average quantity of OptiNose shares traded daily (recently around 236647.2826087). OptiNose's SIR currently stands at 12.88. In other words for every 100,000 OptiNose shares traded daily on the market, roughly 12880 shares are currently held short.

However OptiNose's short interest can also be evaluated against the total number of OptiNose shares, or, against the total number of tradable OptiNose shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OptiNose's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 OptiNose shares in existence, roughly 60 shares are currently held short) or 0.0999% of the tradable shares (for every 100,000 tradable OptiNose shares, roughly 100 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against OptiNose.

Find out more about how you can short OptiNose stock.

OptiNose share dividends

We're not expecting OptiNose to pay a dividend over the next 12 months.

OptiNose share price volatility

Over the last 12 months, OptiNose's shares have ranged in value from as little as $2.32 up to $5.11. A popular way to gauge a stock's volatility is its "beta".

OPTN.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OptiNose's is 0.9278. This would suggest that OptiNose's shares are less volatile than average (for this exchange).

OptiNose overview

OptiNose, Inc. , a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase 3b clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.

OptiNose in the news

There are no recent company news

Frequently asked questions

What percentage of OptiNose is owned by insiders or institutions?
Currently 15.125% of OptiNose shares are held by insiders and 73.262% by institutions.
How many people work for OptiNose?
Latest data suggests 204 work at OptiNose.
When does the fiscal year end for OptiNose?
OptiNose's fiscal year ends in December.
Where is OptiNose based?
OptiNose's address is: 1020 Stony Hill Road, Yardley, PA, United States, 19067
What is OptiNose's ISIN number?
OptiNose's international securities identification number is: US68404V1008
What is OptiNose's CUSIP number?
OptiNose's Committee on Uniform Securities Identification Procedures number is: 68404V100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site